127 related articles for article (PubMed ID: 26505859)
1. Endometriosis Under Estradiol Stimulation Imaged Using 18F-FDG and Its Control After Estradiol Cessation and Progesterone Hormonal Replacement.
Arsenault F; Turcotte É
Clin Nucl Med; 2016 Mar; 41(3):e143-5. PubMed ID: 26505859
[TBL] [Abstract][Full Text] [Related]
2. Increased 18F-FDG uptake of widespread endometriosis mimicking ovarian malignancy.
Ge J; Zuo C; Guan Y; Zhang X
Clin Nucl Med; 2015 Feb; 40(2):186-8. PubMed ID: 25546197
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
Jiang M; Chen P; Sun L; Huang Q; Wu H
Clin Nucl Med; 2015 Feb; 40(2):184-5. PubMed ID: 25546222
[TBL] [Abstract][Full Text] [Related]
4. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
5. The positron emission tomography with F18 17beta-estradiol has the potential to benefit diagnosis and treatment of endometrial cancer.
Yoshida Y; Kurokawa T; Sawamura Y; Shinagawa A; Okazawa H; Fujibayashi Y; Kotsuji F
Gynecol Oncol; 2007 Mar; 104(3):764-6. PubMed ID: 17156828
[TBL] [Abstract][Full Text] [Related]
6. Unusual Case of Postmenopausal Diffuse Endometriosis Mimicking Metastastic Ovarian Malignancy.
Agarwal Sharma R; Lee EY; Vardhanabhuti V; Khong PL; Ngu SF
Clin Nucl Med; 2016 Feb; 41(2):e120-2. PubMed ID: 26462045
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
8. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.
Lerman H; Metser U; Grisaru D; Fishman A; Lievshitz G; Even-Sapir E
J Nucl Med; 2004 Feb; 45(2):266-71. PubMed ID: 14960646
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study.
Fastrez M; Nogarède C; Tondeur M; Sirtaine N; Rozenberg S
Reprod Sci; 2011 Jun; 18(6):540-4. PubMed ID: 21285451
[TBL] [Abstract][Full Text] [Related]
10. Endometriosis with FDG uptake on PET.
Jeffry L; Kerrou K; Camatte S; Metzger U; Lelièvre L; Talbot JN; Lecuru F
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):236-9. PubMed ID: 15541863
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
[TBL] [Abstract][Full Text] [Related]
12. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET in the management of endometrial cancer.
Chao A; Chang TC; Ng KK; Hsueh S; Huang HJ; Chou HH; Tsai CS; Yen TC; Wu TI; Lai CH
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):36-44. PubMed ID: 16167154
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG uptake in endometrial cancer.
Nakahara T; Fujii H; Ide M; Mochizuki Y; Takahashi W; Yasuda S; Shohtsu A; Kubo A
Clin Nucl Med; 2001 Jan; 26(1):82-3. PubMed ID: 11139071
[TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
Sudo S; Hattori N; Manabe O; Kato F; Mimura R; Magota K; Sugimori H; Hirata K; Sakuragi N; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022
[TBL] [Abstract][Full Text] [Related]
16. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG simultaneous PET/MR findings of a malignant transformation and metastases of abdominal wall endometriosis.
Wang H; Xue Q; Shou Y; Chen X; You Z; Yuan J; Gao J; Zhao J
Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3190-3191. PubMed ID: 32335705
[No Abstract] [Full Text] [Related]
18. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
[TBL] [Abstract][Full Text] [Related]
19. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
20. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
